Ir para o conteúdo principal Ir para o menu de navegação principal Ir para o rodapé
Ciências da Saúde
Publicado: 2016-11-17

Hemolytic Anemia Imunne-mediated in dogs

Universidade Estadual do Norte do Paraná
Universidade Federal de Mato Grosso
Universidade Estadual do Norte do Paraná
Universidade Estadual do Norte do Paraná
Universidade Estadual do Norte do Paraná
IMHA immune suystem dogs


Due to the reduction in the number of red blood cells, caused by the immune system, the immune-mediated hemolytic anemia (IMHA) is the most common disease among the hemolytic anemias and occurs more frequently in dogs (Nelson & Couto, 2010), wherein the most affected breeds are Cocker Spaniel, Poodle, Doberman and Collie (ETTINGER; FELDMAN 2004; THRALL et al 2007.). There is no pathognomonic sign for the diagnosis of the immune-mediated hemolytic anemia; however, laboratory findings show regenerative anemia, spherocytosis, positive results in Coombs' test and rarely, monocytes with hemosiderin or erythrocytes phagocytosis, but even with these findings, the primary and secondary IMHA can not be differentiate from each other. Differentiation can only be achieved when there is a deep investigation into the cause of the anemia. The IMHA therapeutics starts with the support treatment and follows with an immunosuppressive therapy. In relation to IMHA Mortality rates, the numbers range from 25% to 50% (Thrall, 2007), or above 70% (CARR; Panciera; Kidd, 2002).


  1. AL-GHAZLAT, S. Immunosuppressive therapy for canine immune-mediated hemolytic anemia. Compendium: Continuing Education for Veterinarians, v. 31, n. 1. p. 33 – 44, 2009.
  2. ADAMO, F. P.; O’ BRIEN, R. T. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs. Journal of the American Veterinary Medical Association, v. 225, n. 8. p. 1211-1216, 2004.
  3. ANDRADE, S. F.; SILVA, M. C.; SILVA D. A.; BIN, L. L. Anemia hemolítica em cães: Relato de caso. Colloquium Agrariae, v. 6, n. 1. p. 50 – 58, 2010.
  4. ARNDT, P.A. GARRATTY, G. The changing spectrum of drug-induced immune hemolytic anemia. Seminars in Hematology, v. 42. p. 137-144, 2005.
  5. BALCH, A.; MACKIN, A. Canine Immune-Mediated Hemolytic Anemia: Pathophysiology. Clinical Signs, and Diagnosis; Compendium: Continuing Education for Veterinarians pratic, v. 29, n. 4. p. 217 – 225, 2007.
  6. BARENT, A; CERUNDOLO, R. Systemic Lupus Erythematosus. Standards of Care, v. 7, n. 4. p. 7 – 12, 2005.
  7. BARKER R. N. Anemia associated with immune responses. In: Feldman BF, Zinkl JG, Jain NC. Veterinary Hematology, 5 ed. Lippincott: Willians e Wilkins, 2000. p. 169-177.
  8. BENNETT, D. FINNETT, S.L., NASH, A.S., et al: Primary autoimmune hemolytic anemia in the dog. Veterinary Record, v. 109, n. 8. p.150–153, 1981.
  9. BRANDÃO, L. P.; HAGIWARA, M. K.; FRANCHINI, L. M.; Anemia Hemolítica Imunomediada em Cão – diagnostico e tratamento. Revista Clinica Veterinária, n. 44. p. 46 – 54, 2003.
  10. BRECHER, M. E; TASWELL, H. F. Hemolytic transfusion reactions. In: Rossi CE, Simon TL, Moss GS, editors. Principles of Transfusion Medicine, Baltimore: Williams & Wilkins; 1991. p. 619 – 635.
  11. BURGESS, K.; MOORE, A.; RAND, W.; COTTER, S. M. Treatment of immune-mediated hemolytic anemia in dogs with cyclosphosphamide. Journal of Veterinary Internal Medicine, v. 14, n. 4. p. 456-462, 2000.
  12. CAMACHO A.T.; GUITIAN F.J.; PALLAS E.; GESTALT J.J.; OLMEDA S.; GOERTHERT H.; TELFORD III S.; SPILEMAN A. Serum Protein Response and renal Failure in Canine Babesia annae Infection. Veterinary Research, v. 36. p. 713-722, 2005.
  13. CARR, A. P.; PANCIERA, D. L.; KIDD, L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 cases. Journal of Veterinary Internal Medicine, v. 16, n. 5. p. 504-509, 2002.
  14. NELSON, R. W.; COUTO, C. G.Medicina Interna de Pequenos Animais. 3 ed. Rio de Janeiro: Elsevier, 2005. p. 1325.
  15. DAY, M. J.; Antigen specificity in canine auto-immune haemolytic anaemia. Veterinary Immunology and Immunopathology, v. 69, n. 2. p. 215 – 224, 1999.
  16. DAY, M. J.; MACKIN, A. J. Immune-mediated haematological disease. In: DAY, M. J. Clinical Immunology of the Dog and Cat. 2. ed. London: Manson Publishing, 2008. p. 94 – 121.
  17. DHALIWAL, G.; CORNETT, P. A.; TIERNEY, L. M. Hemolytic anemia . American Family Physician, v. 69, n. 11. p. 2599 – 2606, 2004.
  18. DUVAL, D.; GIGER, U. Vaccine- associated immune-mediated hemolytic anemia in the dog. Journal of Veterinary Internal Medicine, v. 10, n. 5. p. 290 – 295, 1996.
  19. ETTINGER, S. J.; FELDMAN, E. C.; Tratado de Medicina Interna Veterinária:Doença do cão e do gato, 5 ed. Vol. 2, Rio de Janeiro: Guanabara Koogan. p. 1064, 2004.
  20. FELDMAN, B. F.; MADEWELL, B. R.; O’NEILL, S. Disseminated intravascular coagulation: Antithrombin, plasminogen and coagulation abnormalities in 41 dogs. Journal of the American Veterinary Medical Association, v. 179, n. 2. p. 151-154, 1999.
  21. FIGHERA R.A.; Anemia hemolítica em cães e gatos. Acta Scientiae Veterinariae, v. 35. p. 264-266, 2007.
  22. GARCIA-NAVARRO, C. E. K.; Manual de Hematologia Veterinária, 2 ed. São Paulo: Livraria Varela. p. 44 – 45, 80, 2005.
  23. GIGER, U. Thrombocytopenia. In: WORLD CONGRESS WSAVA/FECAVA /CSAVA, 2006. Prague. Notes of World Congress Wsava/Fecava/Csava, Prague: Czech Small Animal Veterinary Association, 2006. p. 105 – 104.
  24. GOMES, S. G. R.; Transfusão Sanguínea. In: SANTOS, M. M.; FRAGATA, F. S. Emergência e Terapia Intensiva Veterinária em Pequenos Animais, 1ª edição. São Paulo: Roca, 2008. cap. 15. p. 172 – 190.
  25. GOOD, J. Canine Immune Mediated Hemolytic Anemia: Presentation and Treatment. Cornell College of Veterinary Medicine, p. 12, 2002.
  26. GORDON, P. A., BAYLIS, P. H. & BIRD, G. W. G. Tumour-induced autoimmune haemolytic anaemia. British Medical Journal, v. 1. p. 1569-1570, 1976.
  27. HARREL, K. A.; KRISTENSEN, A. T. Canine transfusion reactions and their management. Veterinary Clinics of North America: Small Animal Practice, v. 25. p. 1333 – 1364, 199.
  28. HORGAN, J. E.; ROBERTS, B. K.; SCHERMERHORN, T. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006). Journal of Veterinary Emergency and Critical Care, v. 19, n. 3. p. 254 – 261, 2009.
  29. JONES D.R.; GRUFFYDD-JONES T.J.; STOKES C.R.; BOURNE F.J. Investigation into factors influencing performance of the canine antiglobulin test. Research in Veterinary Science, v. 48. p. 53- 58, 1990.
  30. KIM, J. K.; FACÓ, M. M. M.; LOTITO, A. P. N.; LIPHAUS, B. L.; CARNEIRO, J. D. A.; SILVA, C. A. A. Púrpura trombocitopênica e anemia hemolítica auto-imune em pacientes internados com lúpus eritematoso sistêmico juvenil. Revista Brasileira de Reumatologia. v. 47, n. 1. p. 10 – 15, 2007.
  31. KLAG, A.R.; GIGER, U.; SHOFER, F.S. Idiophatic immune-mediated hemolytic anemia in dogs: 42 cases (1986- 1990). Journal of the American Veterinary Medical Association, v.202, n.5. p. 783- 788, 1993.
  32. LEITE, J. H. A. C.; CARVALHO, L. C. N.; PEREIRA, P. M. Anemia hemolítica imunomediada em cães – relato de três casos. Semina: Ciências Agrárias, v. 32, n. 1. p. 319 – 326, 2011.
  33. MARTINS, D. M.; GAGLIANI, L. H. Importância da citometria de fluxo no diagnóstico diferencial das leucemias. Revista UNILUS Ensino e Pesquisa, v. 5, n. 8. p. 5 – 23, 2008.
  34. MASON, N.; DUVAL, D.; SHOFER, F. S.; GIGER, U. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. Journal of Veterinary Internal Medicine, v. 17, n. 2. p. 206-212, 2003.
  35. MCCULLOUGH, S. Immune-mediated hemolytic anemia: understanding the nemesis. The Veterinary Clinics of North America – Small Animal Practice, v.33, n. 6. p.1295- 1315, 2003.
  36. MCMANUS P.M.; CRAIG L.E. Correlation between leucocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994 -1999). Journal of the American Veterinary Medical Association, v. 218, n. 8. p.1308 - 1313, 2001.
  37. MELVIN, J. D.; WATTS, R. G. Severe hypophosphatemia: a rare cause of intravascular hemolysis. American Journal of Hematology, v. 69, n. 3. p. 223 – 224, 2002.
  38. MELZER, K. J.; WARDROP, K. J.; HALE, A. S. A hemolitic transfusion reaction due to DEA 4 alloantibodies in a dog. Journal of veterinary internal medicine, v. 17, n. 6. p. 931-933, 2003.
  39. MENDONÇA, C. S.; MUNDIM, A. V.; COSTA, A. S.; MORO, T. V. Erliquiose canina: alterações hematológicas em cães domésticos naturalmente infectados. Bioscience Journal, v. 21, n. 1. p. 167 – 174, 2005.
  40. MILLER, E. CVT Update: Diagnosis and treatmente of immune-mediated hemolytic anemia. In BONAGURA, J. D. Kirk´s Current Veterinary Therapy XIII – Small Animal Practice. Saunders, 2000. p. 427 – 434.
  41. MILLER, E. Imunosuppression – an overview. Seminars in Veterinary Medicine and Surgery – Small animal, v. 12, n. 3. p. 144 – 149, 1997.
  42. MILLER, E. The use of cytotoxic agents in the treatment of immune-mediated diseases of dog and cats. Seminars in Veterinary Medicine and Surgery – Small animals, v. 12, n 3. p. 157 – 160, 1997b.
  43. MONCRIEFF, J. C. S; REAGAN, W. J. Human intravenous immunoglobulin therapy. Seminars in Veterinary Medicine and Surgery – Small Animal, v. 12, n.3. p. 178 – 185, 1997.
  44. MONCRIEFF, J. C. S.; TREADWELL, N. G.; MCCULLOUGH, S. M. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. Journal of the American Animal Hospital Association, v. 37, n. 3. p.220–227, 2001.
  45. MORAES, L. F.; TAKAHIRA, R. K. Aplasia medular em cães. Revista de Ciências Agroveterinárias, v. 9, n. 1. p. 99 – 108, 2010.
  46. MULLER, C.S.; FILHO, A. R.; TITTON, D. C.; PAIVA, E. S. Manifestações clínicas e laboratoriais de polimiosite em um caso de leptospirose. Revista Brasileira de Reumatologia, v. 46, n. 6. p. 424 – 427, 2006.
  47. MURRAY, S. C.;GASSER, A.; HESS, R. S. Transient hyperglycaemia in a prediabetic dog treated with prednisone and cyclosporin A. Australian Veterinary Journal, v. 87, n. 9. p. 352-355, 2009.
  48. NAKAGE, A. P. M.; SANTANA, A. E.; CÃPUA, M. L. B; COELHO, P. S. Metodologia e aplicação da citometria de fluxo na hematologia veterinária. Ciência Rural, v. 35, n. 4. p. 966 – 973, 2005.
  49. NELSON, R.W., COUTO, C.G., Medicina Interna de Pequenos Animais. 4.ed. Rio de Janeiro: Elsevier, 2010. p. 1468 .
  50. NOBLE, S.J.; ARMSTRONG, P.J. Bee sting envenomation resulting in secondary immune-mediated hemolytic anemia in two dogs. Journal of the American Veterinary Medical Association, v.214, n.7. p.1021, 1999.
  51. O’NEILL, T.; EDWARDS, G. A.; HOLLOWAY, S. Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis. Journal of Small Animal Practice, v. 45, n. 5. p. 238-243, 2004.
  52. OVERMANN J.A.; SHARKEY L.C.; WEISS D.J.; BORJESSON D.L. Performance of 2 microtiter canine Coombs’ tests. Veterinary Clinical Pathology, v.36, n.2. p.179- 183, 2007.
  53. PEREIRA, P.M. Avaliação de métodos diagnósticos (citometria de fluxo, teste da antiglobulina direta, auto-aglutinação, presença de esferócitos) e achados clinico-laboratoriais na anemia hemolítica imuno-mediada em cães. 2006. 92 p. Dissertação (Doutorado) – Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista “Júlio de Mesquita Filhoâ€, Jaboticabal.
  54. PETROIANU, A., Esplenomegalia induzida por drogas. Acta Medica Portuguesa, v. 24, n. 4. p. 977-982, 2011.
  55. PIEK, C.J. JUNIUS G.; DEKKER, A.; SCHRAUWEN, E.; SLAPPENDEL R. J. TESKE, E. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs. Journal of Veterinary of Internal Medicine, v. 22, n. 2. p. 366-373, 2008.
  56. QUIGLEY, K. A.; BRIAN, J. C.; HAINES, D. M.; JACKSON, M. L.; Application of a direct flow cytometric erythrocyte immunofluorescence assay in dogs with immune-mediated hemolytic anemia and comparison to the direct antiglobulin test. Journal of Veterinary Diagnostic Investigation, v. 13. p. 297 – 300, 2001.
  57. RUIZ, P.; GOMEZ, F.; KING, M.; LOPEZ, R.; DARBY, C.; SCHREIBER, A. D. . In vivo glucocorticoid modulation of guinea-pig splenic macrophage Fc-receptors. Journal of Clinical Investigation, v. 88. p. 149 – 157, 1991.
  58. SAFAR, E. H. ; AZAB, M. E. Anemia and Parasitosis Part: I Erythrocytic Parasites. Parasitologists United Journal, v. 1, n. 2. p. 61 – 76, 2008.
  59. SANCHES, M. P. Anemia hemolítica Imunomediada secundaria a Erliquiose canina: Um caso de sucesso. Disponível em: . Acesso em: 29 out. 2012.
  60. SANCHEZ, M. P.; FERRARIAS, T. M.; MOREIRA, M. A. B.; Anemia Hemolítica Imunomediada em cães: Estudo Retrospectivo de 32 casos. Revista Clínica Veterinária, n. 82. p. 64 – 68, 2009.
  61. SELLON, R. K. Canine immune-mediated hemolytic anemia and thrombocytopenia. In: PROCEEDINGS OF THE EUROPEAN VETERINARY CONFERENCE, 2008. Amsterdam. Scientific Proceedings: Companion Animals Programme. Amsterdam: Voorjaarsdagen, p. 136 – 137, 2008.
  62. STEWART, A.F.; FELDMAN, B.F. Immune-mediated hemolytic anemia. Part I. An overview. Compendium on Continuing of Education for the Practicing Veterinarian, v.15, n.3. p.372- 381, 1993.
  63. STOKOL, T.; BLUE, J. T.; FRENCH, T.W. Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43 cases (1988-1999). Journal of the American Animal Hospital Association, v. 216, n.9. p. 1429 – 36, 2000.
  64. THOMPSON, M. F.; MONCRIEFF, J. C. S.; BROOKS, M. B. Effect of single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia. Journal of the American Animal Hospital Association, v. 40, n. 6. p. 446-454, 2004.
  65. THRALL, M. A.; BAKER, D. C.; CAMPBELL, T. W.; DENICOLA, D.; FETTMAN, M. J.; LASSEN, E. D.; REBAR, A.; WEISER, G. Hematologia e Bioquimica Clínica Veterinária, 1. ed. São Paulo: Rocca. 2007. p. 92 – 109.
  66. TIZARD, I.R. Imunologia Veterinária: Uma Introdução. 6.ed. São Paulo: Rocca, 2002. p. 405 – 478.
  67. WEISS D.J. Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and pure red cell aplasia. Journal of Comparative Pathology, v.138, n.1. p.46- 53, 2008.
  68. WEISS, D. J.; AIRD, B. Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog. Veterinary Clinical Pathology, v. 30, n. 2. p. 67–75, 2001.
  69. WEISS, D. J.; SMITH, S. A. A retrospective study of 19 cases of canine myelofibrosis. Veterinary Clinical Pathology, v. 16, n. 2. p. 174–178, 2002.
  70. WRIGHT MS: Drug-induced hemolytic anemias. Clinical Laboratory Science: Journal of the American Society for Medical Technology, v. 12. p. 8 - 115, 1999.
  71. WHELAN M. F.; O’ TOOLE, T. E.; CHAN, D. L.; ROZANSK, E. A.; DELAFORCADE, A. M.; CRAWFORD, S. L.; COTTER, S. M. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. Journal of Veterinary Emergency and Critical Care, v. 19, n. 2. p. 158 – 164, 2009.

Como Citar

Castilho, R. C., Lima, M. O., Cruz, M. F. R., Marquez, E. S., & Calderón, C. (2016). Hemolytic Anemia Imunne-mediated in dogs. Scientific Electronic Archives, 9(5), 72–84.